Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Drugs used in
chemotherapy such as irinotecan use different ways to stop tumor cells from dividing so they
stop growing or die. Combining thalidomide with irinotecan may kill more tumor cells. This
randomized phase I trial is studying the side effects and best way to give irinotecan and
thalidomide in treating patients with metastatic or unresectable solid tumors